Cardiothoracic & vascular anesthesia

Efficacy of remote ischaemic preconditioning on outcomes following non-cardiac non-vascular surgery: a systematic review and meta-analysis

Perioper Med (Lond)Published Systematic review and meta-analysis of randomised trials

Authors' conclusion

This meta-analysis did not show an improvement in the primary outcomes of interest with the use of RIPC. RIPC was associated with a small improvement in certain surrogate parameters of organ function and small reduction in hospital length of stay.

Study context

Population
Patients undergoing non-cardiac non-vascular (NCNV) surgery36 RCTs
Comparison
Remote ischaemic preconditioning vs no remote ischaemic preconditioning (RIPC)
Outcome
Cardiac and renal morbidity
Methodological detailsrandom effects model, RoB 2 risk-of-bias assessment
  • Random effects model
  • RoB 2 risk-of-bias assessment

Pooled result

As reported in the abstract

Cardiac and renal morbidity (postoperative troponin, AKI)
  • No significant difference in postoperative troponin or AKI

Further pooled results

OutcomeMD (mmHg) (95% CI)P value
Oxygenation (PaO2/FiO2)5 studies, 420 patients; I2 = 89%51.51 (27.32–75.69)P < 0.01
OutcomeEstimateP value
Postoperative serum creatinine9 studies, 914 patients; I2 = 5%MD - 3.81 µmol/L (95% CI - 6.79 to - 0.83)P = 0.01
Renal stress biomarker (NGAL)5 studies, 379 patients; I2 = 86%SMD - 0.66 (95% CI - 1.27 to - 0.06)P = 0.03
Oxidative stress biomarker (malondialdehyde)3 studies, 100 patients; I2 = 91%MD - 1.24 µmol/L (95% CI - 2.4 to - 0.07)P = 0.04
Hospital LOS15 studies, 2110 patients; I2 = 88%MD - 0.99 days (95% CI - 1.75 to - 0.23)P = 0.01

Original publication

Efficacy of remote ischaemic preconditioning on outcomes following non-cardiac non-vascular surgery: a systematic review and meta-analysis. Perioper Med (Lond). Published 10 April 2023. doi:10.1186/s13741-023-00297-0

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.